Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Adv Periodontics ; 13(2): 115-129, 2023 Jun.
Article in English | MEDLINE | ID: mdl-35108460

ABSTRACT

FOCUSED CLINICAL QUESTION: Under what circumstances may a clinician consider dental implant placement at a site exhibiting a focal high or mixed density (HMD) osseous lesion radiologically? SUMMARY: Some conditions and pathologic entities exhibiting high and mixed density radiological appearance pose low risk for dental implant failure or complications following implant surgery. However, other lesions represent contraindications to implant placement, and implant surgery at such sites can result in severe morbidity. CONCLUSION: Potential implant sites exhibiting focal HMD osseous lesions/conditions present varying levels of risk. In most cases, optimal management will include advanced imaging of the site, multidisciplinary consultations, and detailed informed consent to assure full understanding of procedural risks, benefits, and complications. Currently, clinical recommendations rely on case reports, opinion, and usual practice (level 3 evidence). The strength of each recommendation provided in this report is categorized as level C.


Subject(s)
Dental Implants , Dental Implants/adverse effects , Dental Implantation, Endosseous , Contraindications
2.
J Periodontol ; 94(6): 793-804, 2023 06.
Article in English | MEDLINE | ID: mdl-36542391

ABSTRACT

BACKGROUND: Probiotic bacterial supplementation has shown promising results in the treatment of periodontitis and the maintenance of periodontal health. The purpose of this investigation was to evaluate the influence of Lactobacillus reuteri or Bifidobacterium animalis subsp. lactis supplementation with and without prebiotic inulin on biofilm composition using an ex vivo biofilm model. METHODS: Subgingival plaque specimens from three periodontitis-affected human donors were used to grow biofilms on hydroxyapatite disks in media supplemented with varying combinations of prebiotic inulin, Lactobacillus reuteri, and Bifidobacterium animalis subsp. lactis. Relative abundances of bacterial genera present in mature biofilms were evaluated using 16S rRNA next-generation sequencing. Diversity metrics of microbial communities were evaluated using a next-generation microbiome bioinformatics platform. RESULTS: Inulin supplementation produced statistically significant dose-dependent increases in relative abundances of Lactobacillus and Bifidobacterium species (p < 0.001) with concomitant decreases in relative abundances of Streptococcus, Veillonella, Fusobacterium, Parvimonas, and Prevotella species (p < 0.001). Inoculation with L. reuteri or B. animalis subsp. lactis increased the relative abundance of only the supplemented probiotic genera (p < 0.05). Supplemental inulin led to a statistically significant decrease in biofilm alpha diversity (p < 0.001). CONCLUSIONS: The described ex vivo model appears suitable for investigating the effects of probiotic bacteria, prebiotic oligosaccharides, and combinations thereof on biofilm composition and complexity. Within the limitations imposed by this model, results from the present study underscore the potential for prebiotic inulin to modify biofilm composition favorably. Additional research further elucidating biologic rationale and controlled clinical research defining therapeutic benefits is warranted.


Subject(s)
Bifidobacterium animalis , Limosilactobacillus reuteri , Periodontitis , Probiotics , Humans , Prebiotics , Inulin/pharmacology , RNA, Ribosomal, 16S/genetics , Probiotics/pharmacology , Probiotics/therapeutic use , Bacteria , Biofilms
3.
Health Place ; 64: 102390, 2020 07.
Article in English | MEDLINE | ID: mdl-32838900

ABSTRACT

Foreclosure sales permitted investors to purchase large volumes of low-cost residential properties after the last financial crisis, reshaping patterns of property ownership in low-income housing markets across the US. This study links post-foreclosure property acquisitions by investor landlords to subsequent lead poisoning cases among children under age six living in Detroit, Michigan. We find that the odds of exhibiting elevated blood lead levels (≥5 µg/dL) are higher for children living in investor-owned homes purchased through tax foreclosure sale. These findings highlight the potential for property speculation in post-foreclosure housing markets to exacerbate severe and racialized burdens of excess lead toxicity in low-income communities.


Subject(s)
Housing , Lead , Child , Humans , Michigan/epidemiology , Poverty
4.
Am J Forensic Med Pathol ; 41(3): 143-151, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32379077

ABSTRACT

As a result of the 2019 novel human coronavirus (COVID-19) global spread, medical examiner/coroner offices will inevitably encounter increased numbers of COVID-19-infected decedents at autopsy. While in some cases a history of fever and/or respiratory distress (eg, cough or shortness of breath) may suggest the diagnosis, epidemiologic studies indicate that the majority of individuals infected with COVID-19 develop mild to no symptoms. Those dying with-but not of-COVID-19 may still be infectious, however. While multiple guidelines have been issued regarding autopsy protocol in cases of suspected COVID-19 deaths, there is some variability in the recommendations. Additionally, limited recommendations to date have been issued regarding scene investigative protocol, and there is a paucity of publications characterizing COVID-19 postmortem gross and histologic findings. A case of sudden unexpected death due to COVID-19 is presented as a means of illustrating common autopsy findings, as well as diagnostic and biosafety considerations. We also review and summarize the current COVID-19 literature in an effort to provide practical evidence-based biosafety guidance for medical examiner-coroner offices encountering COVID-19 at autopsy.


Subject(s)
Autopsy/standards , Betacoronavirus/isolation & purification , Containment of Biohazards/standards , Coronavirus Infections/mortality , Coronavirus Infections/pathology , Pneumonia, Viral/mortality , Pneumonia, Viral/pathology , Betacoronavirus/genetics , COVID-19 , Centers for Disease Control and Prevention, U.S. , Female , Humans , Middle Aged , Mortuary Practice/methods , Mortuary Practice/standards , Pandemics , Real-Time Polymerase Chain Reaction/standards , SARS-CoV-2 , Triage , United States
5.
Clin Adv Periodontics ; 10(2): 94-102, 2020 06.
Article in English | MEDLINE | ID: mdl-32061062

ABSTRACT

FOCUSED CLINICAL QUESTION: What factors identify the optimal surgical technique when a distal wedge procedure is indicated at a terminal maxillary or mandibular molar site? SUMMARY: Incision design for the distal wedge procedure is based primarily on the dental arch (maxilla or mandible), the distance from the terminal molar to the hamular notch or ascending ramus, and the dimensions of the attached gingiva. CONCLUSIONS: In most situations, favorable clinical results are achievable irrespective of the chosen distal wedge method, and technique selection is based more on operator preference than evidence. However, anatomic limitations can render distal wedge procedures challenging in some cases, and procedural advantages of specific techniques can simplify treatment. One systematic approach to distal wedge technique selection is presented in this report. Additionally, a laser-assisted distal wedge protocol is presented for cases in which unfavorable tooth-to-ramus distance or presence of a prominent external oblique ridge contraindicates conventional distal wedge techniques.


Subject(s)
Mandible , Maxilla , Decision Making , Gingiva , Humans , Mandible/surgery , Maxilla/surgery , Molar
6.
Clin Adv Periodontics ; 10(1): 42-55, 2020 03.
Article in English | MEDLINE | ID: mdl-31609504

ABSTRACT

FOCUSED CLINICAL QUESTION: For a generally healthy patient with no risk indicators for postoperative infection, what is the most appropriate perioperative antibiotic regimen for sinus elevation surgery in terms of reducing postoperative infection risk and minimizing untoward effects? CLINICAL SCENARIO: A 38-year-old female patient in good general and periodontal health presents missing tooth #14 (Fig. ). She reports no systemic conditions, no history of sinusitis, and no allergies. Medications include acetaminophen and ibuprofen as needed for pain. The patient's dentition is minimally restored, with no active caries. Cone-beam computed tomography reveals a clear, pneumatized left maxillary sinus and inadequate bone volume to support dental implant placement (Fig. ). No septa or pathologic lesions are present, the ostium appears patent, and no thickening of the Schneiderian membrane is appreciable. The patient states that she wants to replace her missing molar without restoring adjacent teeth (Figs. and ). [Figure: see text] [Figure: see text] [Figure: see text] [Figure: see text].


Subject(s)
Anti-Bacterial Agents , Maxillary Sinus , Adult , Anti-Bacterial Agents/therapeutic use , Cone-Beam Computed Tomography , Decision Making , Female , Humans , Maxilla , Maxillary Sinus/diagnostic imaging , Maxillary Sinus/surgery , Nasal Mucosa
7.
J Am Pharm Assoc (2003) ; 59(2): 243-251, 2019.
Article in English | MEDLINE | ID: mdl-30638730

ABSTRACT

OBJECTIVES: To describe one independent pharmacy group's experience delivering and being reimbursed for in-home medication coaching, or home visits, to high-risk and high-complexity community-dwelling patients. SETTING: A nondispensing clinical division of an independent community pharmacy in Seattle, Washington. PRACTICE INNOVATION: A community pharmacist-led in-home medication coaching program delivered through partnerships with 3 community-based organizations for referrals and payment over a 4.5-year period. Community-based partners included a state comprehensive care management program, a local health system's cardiology clinic, and the local Area Agency on Aging. EVALUATION: A retrospective analysis of patient demographics, drug therapy problems, interventions, and pharmacy and technician time was conducted with the use of the pharmacy's internal patient care documentation and billing systems from January 1, 2012, to June 31, 2016. RESULTS: A total of 462 home visits (142 initial, 320 follow-up) were conducted with 142 patients. Patients averaged 13 disease states (range 3-31) and 16 medications (range 1-44) at their initial visit. Pharmacists identified an average of 11 drug therapy problems per patient (range 1-36) and performed an average of 13 interventions per patient (range 1-48). The most common drug therapy problem identified was nonadherence, and the most common intervention performed was education. The median pharmacist time in the home was 1.5 hours (range 0.67-2.75) for an initial visit and 1 hour (range 0.08-2.25) for a follow-up visit. CONCLUSION: Home visits can be successfully implemented by community pharmacists to provide care to high-risk and high-complexity community-dwelling patients. Our experience may inform other community pharmacy organizations looking to develop similar home visit services.


Subject(s)
Community Pharmacy Services/organization & administration , House Calls , Medication Therapy Management/organization & administration , Pharmacists/organization & administration , Adult , Aged , Aged, 80 and over , Community Pharmacy Services/economics , Female , House Calls/economics , Humans , Insurance, Pharmaceutical Services/economics , Male , Medication Adherence , Medication Therapy Management/economics , Middle Aged , Pharmacists/economics , Professional Role , Retrospective Studies , Time Factors , Washington
8.
J Am Pharm Assoc (2003) ; 57(2S): S161-S167, 2017.
Article in English | MEDLINE | ID: mdl-28202384

ABSTRACT

OBJECTIVE: Morbidity and mortality associated with opioid use have increased across the nation, growing into what can only be described as an epidemic. SETTING: In Washington State between 2002 and 2004, the statewide death rate attributed to any opioid was 6.6 per 100,000 people, but between 2011 and 2013 it increased to 8.6 per 100,000 people. Pharmacies provide a unique access point for harm reduction services to patients due to their ease of accessibility in the community. PRACTICE DESCRIPTION: In development of a take-home naloxone (THN) program, there were multiple areas that needed to be considered. These included product selection, collaborative practice agreements, training format and materials, managing patient and provider expectations, partnerships, and community perception of the service. PRACTICE INNOVATION: Initial demographics from our experience of people obtaining THN showed a significant difference in the median age from other available programs in the area (57 years vs. 34, 35, and 31). These people tended to be bystanders, instead of end users of opioids, which led to redirecting marketing of our program. We provided community and group trainings for various organizations around the greater Seattle area. We have trained approximately 1400 unique individuals on how to recognize and respond to an opioid overdose, and how to administer naloxone. EVALUATION: One organization reports 20 successful overdose rescues from 99 kits (100% intranasal route) dispensed by our pharmacy (20.2% rescue rate). RESULTS: Since 2012 when our THN program began, we have seen growth of these programs across the state. Based on data through 2015, deaths from heroin in King County have decreased for the first time in the last 7 years, and the number of people seeking treatment for heroin addiction has increased. CONCLUSION: Take-home naloxone programs can be successfully implemented into community pharmacies to increase access and awareness of opioid overdose recognition and response.


Subject(s)
Community Pharmacy Services/organization & administration , Drug Overdose/drug therapy , Naloxone/administration & dosage , Opioid-Related Disorders/complications , Adult , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Cooperative Behavior , Female , Health Services Accessibility , Heroin Dependence/complications , Heroin Dependence/epidemiology , Humans , Male , Middle Aged , Naloxone/supply & distribution , Narcotic Antagonists/administration & dosage , Narcotic Antagonists/supply & distribution , Opioid-Related Disorders/epidemiology , Program Development , Urban Health Services/organization & administration
9.
Skeletal Radiol ; 46(2): 265-271, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27909788

ABSTRACT

Dedifferentiated liposarcoma can arise de novo or as a complication of a preexisting well-differentiated liposarcoma. We describe the radiologic and pathologic features of a long-standing liposarcoma with multiple recurrences in a 59-year-old male. Imaging demonstrated a heterogeneous fat-containing mass in the anterior thigh. The adjacent proximal femur showed irregular cortical new bone, eventually followed by intramedullary osteoblastic involvement and pathologic fracture. Histologic assessment at resection revealed dedifferentiated liposarcoma with low-grade osteosarcomatous component. The patient subsequently developed metastatic lesions in the lungs containing osteoid and osteoblastic bone metastases. We discuss the radiologic and pathologic features of this rare entity that, to our knowledge, has previously been reported to directly involve osseous structures in only one other case and discuss the potential pitfalls in diagnosis.


Subject(s)
Femoral Neoplasms/diagnostic imaging , Femoral Neoplasms/pathology , Liposarcoma/diagnostic imaging , Liposarcoma/pathology , Osteosarcoma/diagnostic imaging , Osteosarcoma/pathology , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/pathology , Diagnosis, Differential , Disease Progression , Humans , Image-Guided Biopsy , Lung Neoplasms/secondary , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Grading , Neoplasm Recurrence, Local , Thigh , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...